| Contact | English |
| Monday - Thursday | 07:30 - 16:30 | |
| Friday | 07:30 - 12:30 | |
| Saturday – Sunday | closed |
| Monday - Thursday | 07:30 - 11:30 | |
| 12:30 - 16:00 | ||
| Friday | 07:30 - 12:30 |
In 9 of 11
men with PE, prilocaine-lidocaine
This article provides a summary of some of the more relevant the peer-reviewed literature pertaining to the medical therapy of premature ejaculation. A retrospective review of peer reviewed publications relevant to the field of premature ejaculation and related medical therapies. Review of safety and efficacy of various medical therapies for premature ejaculation. Selective serotonin release inhibitors have been the most promising agents to date. The on-demand “PRN” use of these agents is more convenient, but its efficacy is less well established.
Chronic use of this class of medications has been associated with minor, but bothersome side effects. More recently, concern over the risk of an increased suicide rate in young men upon initiation of SSRIs has dampened enthusiasm. Recent experience with the use of Tramadol raises the hope that this might prove to be an agent as effective as SSRIs with less worrisome risk of side-effects. New trials on novel formulations of topical solutions are currently underway in the United States. Interest in medical therapy for PE is rapidly increasing and reflected in a disproportionate number of publications in this field in the past few years.
Clinical research in this field is hampered by the complexity, variability among different men and cultures, and subjectivity of PE. Reliable, appropriately controlled and assessed studies are fildena tablet generally lacking and carefully devised, methodically conducted research is much needed. Sadeghi-Nejad H, and Watson R. Premature ejaculation: Current medical treatment and new directions. Interest in premature ejaculation (PE) has been increasing rapidly among all healthcare professionals. cream (EMLA [eutectic mixture
| Remedy | Type | Usage Description | Reported Benefits | Common Side Effects | Notes |
|---|---|---|---|---|---|
| Kegel Exercises | Physical activity | Repeatedly contracting pelvic muscles | Improved control | Muscle soreness | No medication involved |
| Herbal Supplements | Plant-based extract | Taken orally, e.g., ginseng, yohimbe | Possible enhancement of control | Interactions with medications | Evidence varies |
| Acupuncture | Traditional therapy | Stimulating specific body points | Stress reduction | Mild soreness | Limited scientific evidence |
of local anesthetics], Astra
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Levitra Original | 20mg | 92 + 4 Pills | 406.22€ 386.88€ | |
| Tadalista Super Active | 20mg | 20 + 4 Pills | 92.35€ 87.95€ | |
| Cialis Generic | 60mg | 30 + 2 Pills | 85.33€ 81.27€ | |
| Cialis Generic | 40mg | 120 + 8 Pills | 206.98€ 197.12€ | |
| Kamagra Polo | 100 mg | 272 + 12 Pills | 622.94€ 593.28€ | |
| Viagra Super Active | 100mg | 120 + 16 Pills | 198.37€ 188.92€ | |
| Kamagra Gold | 100 mg | 12 Pills | 55.64€ 52.99€ | |
| Kamagra | 100mg | 180 + 6 Pills | 436.79€ 415.99€ | |
| Tadalista Super Active | 20mg | 180 + 20 Pills | 521.59€ 496.75€ | |
| Levitra Generic | 60mg | 180 + 10 Pills | 501.43€ 477.55€ | |
| Cialis Professional | 40mg | 60 + 2 Pills | 262.32€ 249.83€ | |
| Viagra Generic | 150mg | 360 + 10 Pills | 423.48€ 403.31€ | |
| Levitra Original | 20mg | 8 Pills | 65.05€ 61.95€ | |
| Levitra Original | 20mg | 76 + 4 Pills | 344.39€ 327.99€ | |
| Kamagra Polo | 100 mg | 60 + 4 Pills | 189.39€ 180.37€ |
Pharmaceuticals, Wayne, PA, USA)
There are simple ways to treat premature ejaculation and medical intervention can provide individuals with tailored strategies that help solve the issue. Treatment for premature ejaculation often involves a combination of techniques. Behavioural strategies like the stop-start or squeeze techniques can be helpful. Medications such as selective serotonin reuptake inhibitors (SSRIs) or topical anaesthetics may be prescribed. Counselling or therapy can also be beneficial when psychological factors are involved.
Specialists in medicine, nutrition, performance, and diagnostics. BSc (Hons) MBBS MRCGP AFHEA MA (Hons) AFMCP I occasionally experienced premature ejaculation during sex. Not every time, but enough that it became something that was weighing on my mind whenever I got intimate with a girl. My life is so much better now that it seems silly to have wasted so much time not being satisfied. The service is accessible and easily takes away the embarrassment factor.
Answer a few simple questions to get the treatment you need. Hossein Sadeghi-Nejad, MD, FACS, and Richard Watson, MD, FACS A B S T R A C TIntroduction. Premature ejaculation (PE) is the most common form of male sexual dysfunction. Until very recently, scientific investigation of PE has been hampered by a lack of standardized definitions and objective, validated questionnaires. Small numbers of randomized controlled studies evaluating various treatment options have also added to the challenges facing the clinicians who manage PE. was shown to markedly
A recent Medline search (January 2008) for articles related to PE, from 1949 to the present, uncovered a total of 589 references of which 160 articles (27%) had been published within the past 2 years. Much of this recent surge in interest has focused on new and promising medical relief for men who are troubled by this vexing condition. This review, while recognizing the critical importance of an integrated approach to the evaluation and management of PE—coordinating participation on the part of urologists, mental health professionals, endocrinologists, primary care physicians, and other interested healthcare professionals—is directed primarily at providing an update on recent developments in the medical treatment of PE. The definition of PE is still evolving, but the classic triad involved in the definition includes (i) short intravaginal ejaculatory latency time (IELT), (ii) lack of control, and (iii) sexual dissatisfaction [1]. The World Health Organization (WHO) 1994 International Classification of Diseases defines PE as “an inability to delay ejaculation sufficiently to enjoy lovemaking, manifest as either of the following: occurrence of ejaculation before or very soon after the beginning of intercourse (if a time limit is required: before or within 15 seconds of the beginning of intercourse); occurrence of ejaculation in the absence of sufficient erection to make intercourse possible.
The problem is not the result of prolonged absence from sexual activity” [1]. Furthermore, the WHO definition excludes men whose PE is predominately attributed to (i) alcohol, substance abuse, and/or medications; (ii) a sexual context that has led to very high levels of arousal because of the novelty of partner or situation; and (iii) a low frequency of sexual activity [1]. Others have based their diagnosis on the number of penile thrusts occurring before ejaculation, considering less than 8–15 thrusts as the criterion for PE [2,3]. In 2007, responding to the variability of worldwide definitions and the need for a universal standard, the International Society for Sexual Medicine (ISSM) established an ad hoc committee consisting of 21 internationally recognized experts, to establish a new definition of PE. This latest ISSM definition, based on the recommendations of the most active and respected clinical and basic science experts in the field, characterized PE as follows: “Premature ejaculation is a male sexual dysfunction characterized by ejaculation which always or nearly always occurs prior to or within about one minute of vaginal penetration; and inability to delay ejaculation on all or nearly all vaginal penetrations; and negative personal consequences, such as distress, bother, frustration and/or the avoidance of sexual intimacy” [4].
Based on this new definition, some investigators may question the conclusions of previous studies with potentially inadequate patient selection definitions. Other related definitions include primary or lifelong PE—presence of the problem from the onset of initial sexual activity; acquired or late onset PE—indicates that the problem has developed after an initial time of unimpaired ejaculatory function; and situational (vs. global) PE—indicates PE that is limited to specific partner or situation, while the patient enjoys satisfactory intercourse in other contexts [5]. The National Health and Social Life Survey, a probability sample study of sexual behavior in men and women aged 18–59 years, reported a prevalence of 21% among men in the United States [6]. Nathan [7] analyzed the findings of 22 general population sex surveys, and estimated the prevalence of PE to be 35%. improve IELT without any
| Therapy Type | Description | Typical Duration | Success Rate | Noted Benefits | Noted Drawbacks |
|---|---|---|---|---|---|
| SSRI Medications | Selective serotonin reuptake inhibitors, delay ejaculation | 4-12 weeks | 70% | Long-term control | Possible side effects |
| Behavioral Therapy | Techniques like start-stop and squeeze method | Several sessions | 60-80% | No medication needed | Requires patient commitment |
| Topical Anesthetics | Numbing creams or sprays applied to glans penis | As needed | 65-75% | Fast onset | Reduced sensation, partner sensitivity |
| Pelvic Floor Exercises | Exercises to strengthen pubococcygeus muscles | 6-12 weeks | 50-65% | Improves control | Time-consuming |
reported adverse events [28].
| Medication Name | Type | Typical Dosage | Onset Time | Duration of Effect | Common Side Effects | Approval Status | Available By Prescription | Estimated Cost (USD) |
|---|---|---|---|---|---|---|---|---|
| Dapoxetine | SSRI | 30 mg | 1-3 hours | 12-24 hours | Nausea, dizziness, headache | Approved | Yes | 2-5 |
| Paroxetine | SSRI | 20 mg/day | 1-2 hours | 24 hours | Fatigue, dry mouth | Approved | Yes | 1-4 |
| Sertraline | SSRI | 50 mg/day | 2-4 hours | 24 hours | Diarrhea, insomnia | Approved | Yes | 2-4 |
| Topical Anesthetics | Local anesthetic | Varies | Immediate | 30-60 minutes | Loss of sensation in area | Approved | Yes | 3-7 |